BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
Clinical trial NCT05322707 · COMPLETED
Trial details
- NCT number
- NCT05322707
- Sponsor
- Cipla Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-15
- Primary completion
- 2023-08-15
- Enrollment
- 1485
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.